Why Position Sizing Matters More Than Just 'New Buys' in 13Fs
A hedge fund buying a new stock makes headlines, but true conviction is revealed in how a fund sizes its positions over multiple quarters.
Financial media loves to highlight when a famous billionaire buys a new stock. But in the world of 13F analysis, a "New Buy" is often the least important piece of information. The true indicator of a fund manager's conviction is position sizing and how that size changes over time.
The 'Starter Position' Illusion
When a $10 billion fund initiates a new $10 million position in a mid-cap stock, it generates excitement. However, this represents a mere 0.1% of their portfolio. In institutional terms, this is a "starter" or "tracking" position. The manager is keeping an eye on the company, attending earnings calls, and building a model. It is not a high-conviction bet. If the stock drops 50%, the fund barely feels it.
The Power of the Top 10
To understand what a manager truly believes in, you must look at their Top 10 holdings. For concentrated funds, the Top 10 might represent 70% to 90% of their total AUM. This is where their capital is working the hardest. If you see a stock move from the #15 spot (a 2% weight) to the #3 spot (an 8% weight) over three quarters, that is a massive signal of growing conviction, far more powerful than a brand-new 0.1% buy.
Trimming Winners vs. Losing Faith
Conversely, understanding position sizing helps contextualize selling. If a fund's top holding doubles in price over a quarter, its weight in the portfolio will swell. A strict risk-management policy might force the fund manager to sell 20% of their shares simply to rebalance the portfolio back to its target weight. This is called trimming winners. It is a mechanical risk adjustment, not a loss of faith in the underlying company. Always look at whether the share count decreased drastically, or if they merely sold enough to maintain their desired portfolio percentage.
Related Research
Explore all researchFisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026
Victory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Dodge & Cox’s Q4 2025 filing barely moved on headline AUM, but the underlying changes were more interesting: fresh positions in Brookfield, TransUnion and PDD inside a still-diversified value book. The next filing will show whether those adds were conviction moves or just incremental reshuffling.
Apr 17, 2026
American Century’s Q4 2025 filing kept Nvidia and Microsoft on top, but the more revealing changes were the big Netflix increase, fresh utility and industrial additions, and a continued AI-heavy core. The next filing will show whether those side bets keep scaling.
Apr 17, 2026